Perbedaan Diagnos Laboratorium Utama Tbk. dan Sinar Eka Selaras Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Sinar Eka Selaras Tbk. diperdagangkan di Rp284 (kapitalisasi pasar 1,47 T, volume 24 jam 501,8 rb). Perbedaan utamanya: Sinar Eka Selaras Tbk. jauh lebih besar — sekitar 4,7× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Diagnos Laboratorium Utama Tbk. lebih aktif diperdagangkan (963,6 rb vs 501,8 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | ERAL | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 1,47 T |
Volume | 963,6 rb | 501,8 rb |
Lot | 9,64 rb | 5,02 rb |
Perputaran | 217,67 jt | 141,93 jt |
Harga Rata-rata | 225,89 | 282,83 |
Nilai Transaksi | 217,67 jt | 141,93 jt |
Harga Ekuilibrium Indikatif | 226 | 284 |
Volume Ekuilibrium Indikatif | 1 rb | 10 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.
Selengkapnya di halaman ERAL →